The jab is known as VAXELIS and it is the first-ever six-in-one vaccine shot, requiring no additional mixing or reconstituting. Its manufacturer, Sanofi Pasteur Limited, and its distributor, Merck Sharp & Dohne Corp., a subsidiary of Merck & Co., Inc., claim it is "preservative free," but as Dr. Kroner explains, the shot's ingredients are still highly toxic.
One of the main ingredients in VAXELIS is aluminum, a known neurotoxin used in many childhood vaccines. There is also polysorbate 80, a known carcinogen that triggers inflammation in the gut.
VAXELIS also contains glutaraldehyde, a toxin that triggers respiratory problems, as well as formaldehyde, a known carcinogen used in cadaver embalming. Bovine serum from cow blood is also found in VAXELIS, along with:
- Neomycin, an aminoglycoside antibiotic
- Streptomycin, another aminoglycoside antibiotic
- Polymyxin B, an antibiotic
- Ammonium thiocyanate, a chemical used in the manufacturing of crop herbicides
(Related: If you have ever taken a vaccine, studies show that you are more likely to suffer from diseases of the ear and blood, as well as hair loss.)
Children expected to take six-in-one VAXELIS three times for a total of 18 vaccines
One particularly disturbing aspect to VAXELIS and its prescribed use is that drug manufacturers want each child to take the six-in-one shot three separate times: the first at two months, the second at four months and the third at six months.
This means that every child who receives VAXELIS will receive a total of 18 vaccines (three times six, or 6+6+6=18) by the time he or she reaches six months of age. That is a lot of vaccines in a very short period of time.
As of June 2023, the government-run Vaccine Adverse Event Reporting System (VAERS) has logged a total of 501 adverse events associated with VAXELIS.
One of the marketing ploys being used to push VAXELIS on parents is to pretend as though the shot, which covers diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, hepatitis B and invasive disease due to Haemophilus, comes as a single shot, even though each shot contains six different vaccines.
A media report out of Australia further brands the shot as "a one-step job," calling it "new" and "easy to use."
Australia's National Immunization Program has already added VAXELIS to its childhood vaccine schedule, with the aforementioned media report claiming that the shot was "designed to avoid preparation errors and cut time for busy GPs (general practitioners) and other providers."
VAXELIS is being pushed as an alternative to the currently listed Infanrix hexa shots from GlaxoSmithKline (GSK), which also covers the same six conditions but that requires an extra step of reconstituting a pre-filled syringe and a freeze-dried pellet.
"Where a dose of hepatitis B vaccine is given at birth, Vaxelis can be used for supplementary doses of hepatitis B vaccine from the age of six weeks," the product information sheet for VAXELIS states.
"If a second dose of hepatitis B vaccine is required before this age, monovalent hepatitis B vaccine should be used. Vaxelis can be used for a mixed hexavalent/pentavalent/hexavalent combined vaccine immunization schedule."
Because of the serious risks involved with taking VAXELIS, children with uncontrolled neurological disorders, epilepsy, or a history of allergic reaction or encephalopathy to components of the injection, especially for whooping cough vaccines, should not take the shot, according to reports.
The latest news about childhood vaccines can be found at ChemicalViolence.com.
Sources for this article include:
Please contact us for more information.
